Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1960s
|
| gptkbp:ATCCode |
gptkb:V03AC01
|
| gptkbp:CASNumber |
70-51-9
|
| gptkbp:chemicalFormula |
C25H48N6O8
|
| gptkbp:contraindication |
severe renal disease
|
| gptkbp:genericName |
deferoxamine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Desferal
|
| gptkbp:indication |
gptkb:thalassemia_major
sideroblastic anemia transfusional hemosiderosis |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
iron chelator
|
| gptkbp:molecularWeight |
560.7 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intramuscular
subcutaneous intravenous |
| gptkbp:sideEffect |
gptkb:acute_respiratory_distress_syndrome
hearing loss rash hypotension visual disturbances |
| gptkbp:usedFor |
treatment of acute iron poisoning
chronic iron overload |
| gptkbp:bfsParent |
gptkb:Deferoxamine
|
| gptkbp:bfsLayer |
6
|